MNRO

Monro, Inc.

50
Fundamentals54/ 100
Valuation50/ 100
Upside potential60/ 100
Risk potential34/ 100

MNRO offers stronger valuation, but that advantage does not outweigh its weaker overall profile.

TSLA

Tesla, Inc.

52
Fundamentals48/ 100
Valuation27/ 100
Upside potential47/ 100
Risk potential34/ 100

TSLA has a slight edge over MNRO overall on the model score.

MNRO Fundamentals

MetricStatus
Stable
Stable
Under pressure
Healthy

MNRO's balance sheet is currently healthy, and its revenue and profitability are stable, but its cash flow is under pressure.

TSLA Fundamentals

MetricStatus
Healthy
Stable
Under pressure
Strong

TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.

MNRO PE Valuation

MNRO has no meaningful PE right now: it lost money over the past year.

TSLA PE Valuation

CHEAPFAIREXPENSIVE433x867x1300x1733x
CHEAPFAIREXPENSIVE433x867x1300x1733x
LevelPEPriceVs current
Cheap60x$54.70-86%
Fair174x$158-60%
Forward196x$397—
Expensive415x$378-4.9%
Current437x$397—

Historical ranges are pointers, not guarantees.

TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.

MNRO Forward outlook

MetricOutlook
--
Turning to a loss
Stable
Weakening
Limited
High

Analysts expect MNRO's earnings and profitability to decline, with its revenue holding steady.

TSLA Forward outlook

MetricOutlook
Strongly improving
Growth
Growth
Stable
Limited
Low

TSLA has the edge over MNRO on the outlook, with more favorable earnings and revenue expectations.

MNRO Risk to reward

ScenarioChangePrice
Upside+50%$15.51
Downside-34%$6.88

Calculated from the latest close: $10.36 on Nov 12.

MNRO has a better modeled risk to reward balance than TSLA, with more potential upside and less potential downside.

TSLA Risk to reward

ScenarioChangePrice
Upside+30%$515.78
Downside-34%$263.05

Calculated from the latest close: $397.45 on Nov 12.

TSLA trails MNRO on modeled risk to reward, with less potential upside and more potential downside.

MNRO Earnings Per Share

Q4 2023: $1.08Q1 2024: $1.18Q2 2024: $1.09Q3 2024: $0.87Q4 2024: $0.64Q1 2025: $-0.22Q2 2025: $-0.69Q3 2025: $-0.69Q4 2025: $-0.49Q1 2026: $0.03Q2 2026: $0.23Q3 2026: $0.00
Q4 2023: $1.08Q1 2024: $1.18Q2 2024: $1.09Q3 2024: $0.87Q4 2024: $0.64Q1 2025: $-0.22Q2 2025: $-0.69Q3 2025: $-0.69Q4 2025: $-0.49Q1 2026: $0.03Q2 2026: $0.23Q3 2026: $0.00
QuarterTTM EPSYoY
Q3 2026$0.00+$0.69
Q2 2026$0.23+$0.92
Q1 2026$0.03+$0.25
Q4 2025-$0.49-177%
Q3 2025-$0.69-179%
Q2 2025-$0.69-163%
Q1 2025-$0.22-119%
Q4 2024$0.64-41%

MNRO has the edge over TSLA on earnings, with more consistent year-over-year improvement.

TSLA Earnings Per Share

Q4 2023: $4.30Q1 2024: $3.91Q2 2024: $3.55Q3 2024: $3.64Q4 2024: $2.04Q1 2025: $1.82Q2 2025: $1.73Q3 2025: $1.50Q4 2025: $1.08Q1 2026: $1.09Q2 2026: $1.08Q3 2026: $0.91Forward: $2.03
Q4 2023: $4.30Q1 2024: $3.91Q2 2024: $3.55Q3 2024: $3.64Q4 2024: $2.04Q1 2025: $1.82Q2 2025: $1.73Q3 2025: $1.50Q4 2025: $1.08Q1 2026: $1.09Q2 2026: $1.08Q3 2026: $0.91Forward: $2.03
QuarterTTM EPSYoY
Forward$2.03+123%
Q3 2026$0.91-39%
Q2 2026$1.08-38%
Q1 2026$1.09-40%
Q4 2025$1.08-47%
Q3 2025$1.50-59%
Q2 2025$1.73-51%
Q1 2025$1.82-53%
Q4 2024$2.04-53%

TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.

MNRO Quarterly Revenue

Q4 2023: $318MQ1 2024: $310MQ2 2024: $293MQ3 2024: $301MQ4 2024: $306MQ1 2025: $295MQ2 2025: $301MQ3 2025: $289MQ4 2025: $293MQ1 2026: $274MQ2 2026: $287MQ3 2026: $284M
Q4 2023: $318MQ1 2024: $310MQ2 2024: $293MQ3 2024: $301MQ4 2024: $306MQ1 2025: $295MQ2 2025: $301MQ3 2025: $289MQ4 2025: $293MQ1 2026: $274MQ2 2026: $287MQ3 2026: $284M
QuarterRevenueYoY
Q3 2026$283.6M-1.8%
Q2 2026$287.1M-4.6%
Q1 2026$273.8M-7.2%
Q4 2025$293.4M-4%
Q3 2025$288.9M-4.1%
Q2 2025$301M+2.7%
Q1 2025$295M-4.9%
Q4 2024$305.8M-3.7%

MNRO's revenue has slid since its 2022 peak: $284M last quarter, down 1.8% from the same quarter a year ago.

TSLA Quarterly Revenue

Q4 2023: $25.2BQ1 2024: $21.3BQ2 2024: $25.5BQ3 2024: $25.2BQ4 2024: $25.7BQ1 2025: $19.3BQ2 2025: $22.5BQ3 2025: $28.1BQ4 2025: $24.9BQ1 2026: $22.4BQ2 2026: $28.2BQ3 2026: $28B
Q4 2023: $25.2BQ1 2024: $21.3BQ2 2024: $25.5BQ3 2024: $25.2BQ4 2024: $25.7BQ1 2025: $19.3BQ2 2025: $22.5BQ3 2025: $28.1BQ4 2025: $24.9BQ1 2026: $22.4BQ2 2026: $28.2BQ3 2026: $28B
QuarterRevenueYoY
Q3 2026$28B-0.2%
Q2 2026$28.2B+26%
Q1 2026$22.4B+16%
Q4 2025$24.9B-3.1%
Q3 2025$28.1B+12%
Q2 2025$22.5B-12%
Q1 2025$19.3B-9.2%
Q4 2024$25.7B+2.1%

TSLA has the edge over MNRO on sales, with more consistent year-over-year improvement.

MNRO Free Cash Flow

Q4 2023: $29MQ1 2024: −$12MQ2 2024: $17MQ3 2024: $58MQ4 2024: $8MQ1 2025: $23MQ2 2025: −$9MQ3 2025: $27MQ4 2025: $9MQ1 2026: $12MQ2 2026: −$38MQ3 2026: $29M
Q4 2023: $29MQ1 2024: −$12MQ2 2024: $17MQ3 2024: $58MQ4 2024: $8MQ1 2025: $23MQ2 2025: −$9MQ3 2025: $27MQ4 2025: $9MQ1 2026: $12MQ2 2026: −$38MQ3 2026: $29M
QuarterFree cash flowYoY
Q3 2026$28.8M+8.2%
Q2 2026-$37.9M-$28.6M
Q1 2026$12.4M-47%
Q4 2025$9.1M+15%
Q3 2025$26.6M-54%
Q2 2025-$9.3M-156%
Q1 2025$23.2M+$35.1M
Q4 2024$7.9M-73%

MNRO still generates free cash flow, though less than at its 2022 peak: $12M over the past year.

TSLA Free Cash Flow

Q4 2023: $2.1BQ1 2024: −$2.5BQ2 2024: $1.3BQ3 2024: $2.7BQ4 2024: $2BQ1 2025: $664MQ2 2025: $146MQ3 2025: $4BQ4 2025: $1.4BQ1 2026: $1.4BQ2 2026: −$1.1BQ3 2026: $1.5B
Q4 2023: $2.1BQ1 2024: −$2.5BQ2 2024: $1.3BQ3 2024: $2.7BQ4 2024: $2BQ1 2025: $664MQ2 2025: $146MQ3 2025: $4BQ4 2025: $1.4BQ1 2026: $1.4BQ2 2026: −$1.1BQ3 2026: $1.5B
QuarterFree cash flowYoY
Q3 2026$1.5B-62%
Q2 2026-$1.1B-848%
Q1 2026$1.4B+117%
Q4 2025$1.4B-30%
Q3 2025$4B+46%
Q2 2025$146M-89%
Q1 2025$664M+$3.2B
Q4 2024$2B-1.6%

TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.

MNRO Total Shares

Q4 2023: 32MQ1 2024: 32MQ2 2024: 31MQ3 2024: 31MQ4 2024: 31MQ1 2025: 30MQ2 2025: 30MQ3 2025: 31MQ4 2025: 31MQ1 2026: 30MQ2 2026: 30MQ3 2026: 31M
Q4 2023: 32MQ1 2024: 32MQ2 2024: 31MQ3 2024: 31MQ4 2024: 31MQ1 2025: 30MQ2 2025: 30MQ3 2025: 31MQ4 2025: 31MQ1 2026: 30MQ2 2026: 30MQ3 2026: 31M
PeriodChange %Net change
Quarterly+3.8%+1.1M shares
1 year-0.2%-68K shares
3 years-3%-977K shares
5 years-8%-2.7M shares
Available history-7.9%-2.7M shares

MNRO has the edge over TSLA on shareholder dilution, with a more favorable share count trend.

TSLA Total Shares

Q4 2023: 3.5BQ1 2024: 3.5BQ2 2024: 3.5BQ3 2024: 3.5BQ4 2024: 3.5BQ1 2025: 3.5BQ2 2025: 3.5BQ3 2025: 3.5BQ4 2025: 3.5BQ1 2026: 3.5BQ2 2026: 3.5BQ3 2026: 3.5B
Q4 2023: 3.5BQ1 2024: 3.5BQ2 2024: 3.5BQ3 2024: 3.5BQ4 2024: 3.5BQ1 2025: 3.5BQ2 2025: 3.5BQ3 2025: 3.5BQ4 2025: 3.5BQ1 2026: 3.5BQ2 2026: 3.5BQ3 2026: 3.5B
PeriodChange %Net change
Quarterly0%+1M shares
1 year+0.4%+15M shares
3 years+1.4%+48M shares
5 years+5.1%+172M shares
Available history+33%+886M shares

TSLA has 3.5B diluted shares, about the same as a year ago.

MNRO Net Leverage

Q4 2023: 0.8xQ1 2024: 0.9xQ2 2024: 1.0xQ3 2024: 0.6xQ4 2024: 0.8xQ1 2025: 1.0xQ2 2025: 1.7xQ3 2025: 1.5xQ4 2025: 1.2xQ1 2026: 1.0xQ2 2026: 1.5xQ3 2026: 1.5x
Q4 2023: 0.8xQ1 2024: 0.9xQ2 2024: 1.0xQ3 2024: 0.6xQ4 2024: 0.8xQ1 2025: 1.0xQ2 2025: 1.7xQ3 2025: 1.5xQ4 2025: 1.2xQ1 2026: 1.0xQ2 2026: 1.5xQ3 2026: 1.5x
QuarterNet LeverageStatus
Q3 20261.5xHealthy
Q2 20261.5xHealthy
Q1 20261.0xHealthy
Q4 20251.2xHealthy
Q3 20251.5xHealthy
Q2 20251.7xHealthy
Q1 20251.0xVery low
Q4 20240.8xVery low

MNRO's net debt is about 1.5 years of its operating earnings (EBITDA), about the same as a year ago.

TSLA Net Leverage

Q4 2023: -1.1xQ1 2024: -0.8xQ2 2024: -0.9xQ3 2024: -1.1xQ4 2024: -1.0xQ1 2025: -1.1xQ2 2025: -1.1xQ3 2025: -1.4xQ4 2025: -1.1xQ1 2026: -0.9xQ2 2026: -0.8xQ3 2026: -1.1x
Q4 2023: -1.1xQ1 2024: -0.8xQ2 2024: -0.9xQ3 2024: -1.1xQ4 2024: -1.0xQ1 2025: -1.1xQ2 2025: -1.1xQ3 2025: -1.4xQ4 2025: -1.1xQ1 2026: -0.9xQ2 2026: -0.8xQ3 2026: -1.1x
QuarterNet LeverageStatus
Q3 2026-1.1xNet Cash
Q2 2026-0.8xNet Cash
Q1 2026-0.9xNet Cash
Q4 2025-1.1xNet Cash
Q3 2025-1.4xNet Cash
Q2 2025-1.1xNet Cash
Q1 2025-1.1xNet Cash
Q4 2024-1.0xNet Cash

TSLA has the edge over MNRO on leverage, with a lower net debt burden relative to earnings.

MNRO Weekly Momentum

MetricValueStatus
RSI34.0Neutral
Stochastic5.4Oversold

MNRO's weekly RSI is 34 (neutral) and its Stochastic is 5 (oversold).

TSLA Weekly Momentum

MetricValueStatus
RSI54.3Neutral
Stochastic72.6Neutral

TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).

MNRO PE vs Consumer Cyclical Sector

MetricMNROSector medianRelative
PE58x18x219% above
PE %854738 pts above

MNRO has the edge over TSLA on valuation relative to its sector.

TSLA PE vs Consumer Cyclical Sector

MetricTSLASector medianRelative
PE437x18x2,324% above
PE %844737 pts above

TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.

MNRO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.718% below
20 week MA$13.523% below
50 week MA$16.437% below
100 week MA$16.838% below
200 week MA$25.159% below

MNRO is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.

TSLA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$376.05.7% above
20 week MA$364.09.2% above
50 week MA$393.61% above
100 week MA$372.16.8% above
200 week MA$296.934% above

TSLA has the edge over MNRO on trend strength, trading above more of its moving averages.

MNRO Yearly ROI

YearStart priceEnd priceROI
2020$78.9$53.1-33%
2021$53.1$59.2+11%
2022$59.2$45.2-24%
2023$45.2$29.3-35%
2024$29.3$24.8-16%
2025$24.8$20.8-16%
2026 YTD$20.8$10.4-50%

MNRO has finished four years in a row lower, and it's down 50% so far in 2026.

TSLA Yearly ROI

YearStart priceEnd priceROI
2020$28.7$220.6+669%
2021$220.6$355.7+61%
2022$355.7$123.2-65%
2023$123.2$248.5+102%
2024$248.5$431.7+74%
2025$431.7$475.2+10%
2026 YTD$475.2$397.5-16%

TSLA has the edge over MNRO on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key